Concepedia
Statistics
Publications
14
Citations
3K
H-Index
12
Active since
1982
Affiliations
University of Vermont(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Vermont Department of Health
Roger Williams Medical Center
Merck Biopharma Co., Ltd. (Japan)
Richard P. Tonino is an author at University of Vermont specializing in medicine, bone metabolism, and osteoporosis.
Publications per year
1982–2004
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.4K citations · Full text
Medicine, Pharmacotherapy, Bone Metabolism +13
Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
Thomas J. Schnitzer, Henry G. Bone, Gaetano Crepaldi et al. · Aging Clinical and Experimental Research · 2000 · 395 citations
Medicine, Clinical Pharmacy, Pharmacotherapy +14
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women<sup>1</sup>
Richard P. Tonino, Pierre J. Meunier, Ronald Emkey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 337 citations
Medicine, Pharmacotherapy, Bone Augmentation +16
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
Joseph Tucci, Richard P. Tonino, Ronald Emkey et al. · The American Journal of Medicine · 1996 · 222 citations
Medicine, Endocrinology, Bone Metabolism +10
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Richard P. Tonino · The Journal of Clinical Endocrinology & Metabolism · 2000 · 190 citations
Medicine, Orthopedic Surgery, Bone Metabolism +13
1–5 of 14